{
  "pmcid": "12269756",
  "sha256": "c8c40ae1f9fce2710b9b7d30eea0a1deff6cf3b1c4d3d5f0735c97fe335bb959",
  "timestamp_utc": "2025-11-09T22:20:25.200418+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 9.943333333333332,
    "reading_ease": 41.58500000000001,
    "word_count": 210
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial on Amiodarone for POAF Prevention in CABG Patients"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "This randomised controlled trial included 454 patients"
      },
      "Participants": {
        "score": 2,
        "evidence": "moderate and high-risk patients undergoing elective coronary artery bypass grafting (CABG)"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Moderate and high-risk patients received amiodarone with beta blockers (Amiodarone group), while low-risk patients received beta blockers only."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the effect of amiodarone on POAF incidence and onset timing"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was POAF incidence, measured over the hospital stay."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, with allocation concealment via sealed envelopes."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not applied."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "227 patients were randomised to each group."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The relative risk reduction was 27% (RR = 0.27, 95% CI = 0.105-0.689, p = 0.006)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: N/A."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 16,
    "max_score": 25
  }
}